Nevertheless, GA administration for 14 consecutive days prior to LPS administration resulted in SA-AKI attenuation, as indicated by marked decrease in IL-1β, MYD88, TLR4, and TNF-α protein expressions. The gene discussed is MYD88; the disease is acute kidney injury.